The class II transactivator CIITA is a transcriptional integrator

Microbes and Infection

Volumn 1, Issue 11, 1999, Pages 863-869

  Fontes, Joseph D ^a   Kanazawa, Satoshi ^a   Nekrep, Nada ^a   Peterlin, B Matija ^a  

^a Depts Med Microbiol and Immunol   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXAMETHASONE; DNA BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

GENE SWITCHING; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0032719226     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00232-4     Document Type: Article

References (61)

1. Babb R., Cleary M.A., Herr W. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain. Mol. Cell Biol. 17:1997;7295-7305.
2. Basta P., Sherman P., Ting J. Molecular identification of regulatory DNA sequences for basal and gamma-interferon-induced expression of HLA DR alpha in human multiforme glioblastoma cell lines. Ann. NY Acad. Sci. 540:1988;255-257.
3. Bontron S., Ucla C., Mach B., Steimle V. Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy. Mol. Cell Biol. 17:1997;4249-4258.
4. Brown J.A., Rogers E.M., Boss J.M. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. Nucleic Acids Res. 26:1998;4128-4136.
5. Cepek K.L., Chasman D.I., Sharp P.A. Sequence-specific DNA binding of the B cell-specific coactivator OCA-B. Genes Dev. 10:1996;2079-2088.
6. Chang C.H., Flavell R.A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. M. 181:1995;765-767.
7. Chang C.H., Fontes J.D., Peterlin M., Flavell R.A. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. M. 180:1994;1367-1374.
8. Chin K.C., Li G., Ting J.P. Activation and transdominant suppression of MHC class II and HLA-DMB promoters by a series of C-terminal class II transactivator deletion mutants. J. Immunol. 159:1997;2789-2794.
9. Chin K.C., Li G.G., Ting J.P. Importance of acidic proline/serine/threonine-rich and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA. 94:1997;2501-2506.
10. Cogswell J.P., Austin J., Ting J.P. The W element is a positive regulator of HLA-DRA transcription in various DR+ cell types. J. Immunol. 146:1991;1361-1367.
11. Collinge M., Pardi R., Bender J.R. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion. J. Immunol. 161:1998;1589-1593.
12. Douhan J., Lieberson R., Knoll J.H., Zhou H., Glimcher L.H. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator. J. Exp. M. 185:1997;1885-1895.
13. Fontes J.D., Jabrane-Ferrat N., Peterlin B.M. Assembly of functional regulatory complexes on MHC class II promoters in vivo. J. Mol. Biol. 270:1997;336-345.
14. Fontes J.D., Jabrane-Ferrat N., Toth C.R., Peterlin B.M. Binding and cooperative interactions between two B cell-specific transcriptional coactivators. J. Exp. M. 183:1996;2517-2521.
15. Fontes J.D., Jiang B., Peterlin B.M. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res. 25:1997;2522-2528.
16. Fontes J.D., Kanazawa S., Jean D., Peterlin B.M. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell Biol. 19:1999;941-947.
17. Glimcher L.H., Kara C.J. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:1992;13-49.
18. Gobin S.J., Peijnenburg A., Keijsers V., van denElsen P.J. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity. 6:1997;601-611.
19. Goldman P.S., Tran V.K., Goodman R.H. The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Prog. Horm. Res. 52:1997;103-119.
20. Goodrich J.A., Hoey T., Thut C.J., Admon A., Tjian R. Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell. 75:1993;519-530.
21. Gstaiger M., Knoepfel L., Georgiev O., Schaffner W., Hovens C.M. A B-cell coactivator of octamer-binding transcription factors. Nature. 373:1995;360-362.
22. Horvai A.E., Xu L., Korzus E., Brard G., Kalafus D., Mullen T.M., Rose D.W., Rosenfeld M.G., Glass C.K. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. USA. 94:1997;1074-1079.
23. Jabrane-Ferrat N., Fontes J.D., Boss J.M., Peterlin B.M. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol. Cell Biol. 16:1996;4683-4690.
24. Janknecht R., Hunter T. Versatile molecular glue. Transcriptional control, Curr. Biol. 6:1996;951-954.
25. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
26. Kara C.J., Glimcher L.H. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science. 252:1991;709-712.
27. Kara C.J., Glimcher L.H. Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo. J. Immunol. 150:1993;4934-4942.
28. Kern I., Steimle V., Siegrist C.A., Mach B. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7:1995;1295-1299.
29. Klemm R.D., Goodrich J.A., Zhou S., Tjian R. Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with VP16 and TFIIB that mediate transcriptional activation. Proc. Natl. Acad. Sci. USA. 92:1995;5788-5792.
30. Kretsovali A., Agalioti T., Spilianakis C., Tzortzakaki E., Merika M., Papamatheakis J. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell Biol. 18:1998;6777-6783.
31. Lee Y.J., Han Y., Lu H.T., Nguyen V., Qin H., Howe P.H., Hocevar B.A., Boss J.M., Ransohoff R.M., Benveniste E.N. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:1997;2065-2075.
32. Louis-Plence P., Moreno C.S., Boss J.M. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159:1997;3899-3909.
33. Luo Y., Ge H., Stevens S., Xiao H., Roeder R.G. Coactivation by OCA-B: definition of critical regions and synergism with general cofactors. Mol. Cell Biol. 18:1998;3803-3810.
34. Mahanta S.K., Scholl T., Yang F.C., Strominger J.L. Transactivation by CIITA the type II bare lymphocyte syndrome-associated factor requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA. 94:1997;6324-6329.
35. Martin B.K., Chin K.C., Olsen J.C., Skinner C.A., Dey A., Ozato K., Ting J.P. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity. 6:1997;591-600.
36. Masternak K., Barras E., Zufferey M., Conrad B., Corthals G., Aebersold R., Sanchez J.C., Hochstrasser D.F., Mach B., Reith W. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:1998;273-277.
37. Moreno C.S., Rogers E.M., Brown J.A., Boss J.M. Regulatory factor X a bare lymphocyte syndrome transcription factor is a multimeric phosphoprotein complex. J. Immunol. 158:1997;5841-5848.
38. Nakajima T., Uchida C., Anderson S.F., Lee C.G., Hurwitz J., Parvin J.D., Montminy M. RNA helicase A mediates association of CBP with RNA polymerase II. Cell. 90:1997;1107-1112.
39. Otten L.A., Steimle V., Bontron S., Mach B. Quantitative control of MHC class II expression by the transactivator CIITA. Eur. J. Immunol. 28:1998;473-478.
40. Piskurich J.F., Wang Y., Linhoff M.W., White L.C., Ting J.P. Identification of distinct regions of 5' flanking DNA that mediate constitutive IFN-gamma STAT1 and TGF-beta-regulated expression of the class II transactivator gene. J. Immunol. 160:1998;233-240.
41. Pouponnot C., Jayaraman L., Massague J. Physical and functional interaction of SMADs and p300/CBP. J. Biol. Chem. 273:1998;22865-22868.
42. Reith W., Kobr M., Emery P., Durand B., Siegrist C.A., Mach B. Cooperative binding between fctors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269:1994;20020-20025.
43. Reith W., Siegrist C.A., Durand B., Barras E., Mach B. Function of major histocopatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA. 91:1994;554-558.
44. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity. 2:1995;533-543.
45. Sauter P., Matthias P. The B cell-specific coactivator OBF-1 (OCA-B Bob-1) is inducible in T cells and its expression is dispensable for IL-2 gene induction. Immunobiology. 198:1997;207-216.
46. Scholl T., Mahanta S.K., Strominger J.L. Specific complex formation between the type II bare lymphocyte syndrome- associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA. 94:1997;6330-6334.
47. Silacci P., Mottet A., Steimle V., Reith W., Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. M. 180:1994;1329-1336.
48. Sims T.N., Goes N.B., Ramassar V., Urmson J., Halloran P.F. In vivo class II transactivator expression in mice is induced by a non-interferon-gamma mechanism in response to local injury. Transplantation. 64:1997;1657-1664.
49. Somasundaram K., El-Deiry W.S. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene. 14:1997;1047-1057.
50. Steimle V., Durand B., Barras E., Zufferey M., Hadam M.R., Mach B., Reith W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1995;1021-1032.
51. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency. Cell. 75:1993;135-146.
52. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 265:1994;106-109.
53. Tsang S.Y., Nakanishi M., Peterlin B.M. B cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc. Natl. Acad. Sci. USA. 85:1988;8598-8602.
54. Tsang S.Y., Nakanishi M., Peterlin B.M. Mutational analysis of the DRA promoter: cis-acting sequences and trans- acting factors. Mol. Cell Biol. 10:1990;711-719.
55. Vilen B.J., Cogswell J.P., Ting J.P. Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function. Mol. Cell Biol. 11:1991;2406-2415.
56. Villard J., Lisowska-Grospierre B., van denElsen P., Fischer A., Reith W., Mach B. Mutation of RFXAP a regulator of MHC class II genes in primary MHC class II deficiency. N. Engl. J. M. 337:1997;748-753.
57. Westerheide S.D., Louis-Plence P., Ping D., He X.F., Boss J.M. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J. Immunol. 158:1997;4812-4821.
58. Wright K.L., Chin K.C., Linhoff M., Skinner C., Brown J.A., Boss J.M., Stark G.R., Ting J.P. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;6267-6272.
59. Zhou H., Glimcher L.H. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA one of the defective genes in type II MHC combined immune deficiency. Immunity. 2:1995;545-553.
60. Zhou H., Su H.S., Zhang X., DouhanIii J., Glimcher L.H. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. 158:1997;4741-4749.
61. Zwilling S., Dieckmann A., Pfisterer P., Angel P., Wirth T. Inducible expression and phosphorylation of coactivator BOB. 1/OBF. 1 in T cells. Science. 277:1997;221-225.